PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Livzon Pharmaceutical Group Inc (1513.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCNE100001QV5
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market CapHK$33.18B
EPSHK$1.57
PE Ratio11.44
Revenue (TTM)HK$12.80B
Gross Profit (TTM)HK$7.75B
EBITDA (TTM)HK$2.80B
Year RangeHK$21.50 - HK$29.05
Target PriceHK$29.44

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Livzon Pharmaceutical Group Inc

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Livzon Pharmaceutical Group Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%25.00%NovemberDecember2024FebruaryMarchApril
9.05%
17.25%
1513.HK (Livzon Pharmaceutical Group Inc)
Benchmark (^GSPC)

S&P 500

Returns By Period

Livzon Pharmaceutical Group Inc had a return of 7.25% year-to-date (YTD) and -3.50% in the last 12 months. Over the past 10 years, Livzon Pharmaceutical Group Inc had an annualized return of 8.94%, while the S&P 500 had an annualized return of 10.37%, indicating that Livzon Pharmaceutical Group Inc did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date7.25%5.06%
1 month-5.65%-3.23%
6 months9.05%17.14%
1 year-3.50%20.62%
5 years (annualized)9.65%11.54%
10 years (annualized)8.94%10.37%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-1.45%15.13%-2.74%
20233.22%-9.94%1.08%3.43%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 1513.HK is 41, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of 1513.HK is 4141
Livzon Pharmaceutical Group Inc(1513.HK)
The Sharpe Ratio Rank of 1513.HK is 4343Sharpe Ratio Rank
The Sortino Ratio Rank of 1513.HK is 3939Sortino Ratio Rank
The Omega Ratio Rank of 1513.HK is 3838Omega Ratio Rank
The Calmar Ratio Rank of 1513.HK is 4444Calmar Ratio Rank
The Martin Ratio Rank of 1513.HK is 4242Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Livzon Pharmaceutical Group Inc (1513.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


1513.HK
Sharpe ratio
The chart of Sharpe ratio for 1513.HK, currently valued at -0.17, compared to the broader market-2.00-1.000.001.002.003.00-0.17
Sortino ratio
The chart of Sortino ratio for 1513.HK, currently valued at -0.03, compared to the broader market-4.00-2.000.002.004.00-0.03
Omega ratio
The chart of Omega ratio for 1513.HK, currently valued at 1.00, compared to the broader market0.501.001.501.00
Calmar ratio
The chart of Calmar ratio for 1513.HK, currently valued at -0.14, compared to the broader market0.001.002.003.004.005.00-0.14
Martin ratio
The chart of Martin ratio for 1513.HK, currently valued at -0.46, compared to the broader market0.0010.0020.0030.00-0.46
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.76, compared to the broader market-2.00-1.000.001.002.003.001.76
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.57, compared to the broader market-4.00-2.000.002.004.002.57
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.31
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.001.002.003.004.005.001.33
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.04, compared to the broader market0.0010.0020.0030.007.04

Sharpe Ratio

The current Livzon Pharmaceutical Group Inc Sharpe ratio is -0.17. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2024FebruaryMarchApril
-0.17
1.74
1513.HK (Livzon Pharmaceutical Group Inc)
Benchmark (^GSPC)

Dividends

Dividend History

Livzon Pharmaceutical Group Inc granted a 6.73% dividend yield in the last twelve months. The annual payout for that period amounted to HK$1.74 per share.


PeriodTTM2023202220212020201920182017201620152014
DividendHK$1.74HK$1.74HK$1.51HK$1.51HK$1.25HK$1.37HK$1.89HK$0.34HK$0.27HK$0.06HK$0.22

Dividend yield

6.73%7.22%5.76%5.28%4.17%5.63%10.81%0.93%1.31%0.34%1.33%

Monthly Dividends

The table displays the monthly dividend distributions for Livzon Pharmaceutical Group Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024HK$0.00HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$1.74HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$1.51HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$1.51HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$1.25HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$1.37HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$1.89HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2017HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.34HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2016HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.27HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2015HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.06HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2014HK$0.22HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%6.7%
Livzon Pharmaceutical Group Inc has a dividend yield of 6.73%, which means its dividend payment is significantly above the market average.
Payout Ratio
200.0%400.0%600.0%800.0%110.8%
Livzon Pharmaceutical Group Inc has a payout ratio of 110.81%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-27.25%
-4.57%
1513.HK (Livzon Pharmaceutical Group Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Livzon Pharmaceutical Group Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Livzon Pharmaceutical Group Inc was 59.40%, occurring on Jan 3, 2019. Recovery took 356 trading sessions.

The current Livzon Pharmaceutical Group Inc drawdown is 27.25%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-59.4%Mar 21, 2018194Jan 3, 2019356Jun 15, 2020550
-48.69%Jul 16, 2020554Oct 12, 2022
-39.56%May 27, 2015166Jan 22, 2016322May 17, 2017488
-37.35%Oct 20, 201483Feb 16, 201534Apr 10, 2015117
-32.73%Feb 18, 201448Apr 28, 2014117Oct 17, 2014165

Volatility

Volatility Chart

The current Livzon Pharmaceutical Group Inc volatility is 7.72%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2024FebruaryMarchApril
7.72%
3.30%
1513.HK (Livzon Pharmaceutical Group Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Livzon Pharmaceutical Group Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items